James L Hutchinson Selected Research

vapiprost

1/2021

Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James L Hutchinson Research Topics

Disease

2	Thrombosis (Thrombus) 01/2021 - 06/2017
2	Hemorrhage 01/2021 - 12/2020
1	Neoplasms (Cancer) 01/2021
1	Obesity 01/2021
1	Tics (Tic) 12/2020
1	Premature Obstetric Labor (Premature Labor) 01/2014
1	Premature Birth (Birth, Premature) 01/2014
1	Inflammation (Inflammations) 07/2011
1	Salmonella Infections (Salmonellosis) 08/2009

Drug/Important Bio-Agent (IBA)

1	Phosphotransferases (Kinase)IBA 01/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021
1	vapiprostIBA 01/2021
1	proto-oncogene proteins pimIBA 01/2021
1	Prostaglandin H2 Thromboxane A2 ReceptorsIBA 01/2021
1	Cyclooxygenase InhibitorsIBA 01/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2021
1	SphingolipidsIBA 01/2021
1	thrombin receptor peptide (42-47)IBA 12/2020
1	collagen-related peptideIBA 12/2020
1	TicagrelorIBA 12/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2020
1	Glycoproteins (Glycoprotein)IBA 12/2020
1	Collagen ReceptorsIBA 12/2020
1	PhosphotyrosineIBA 06/2017
1	src-Family KinasesIBA 06/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2017
1	CollagenIBA 06/2017
1	Protein Isoforms (Isoforms)IBA 06/2017
1	LigandsIBA 01/2014
1	LipoxinsIBA 07/2011
1	Annexin A1IBA 07/2011
1	HLA-DR Antigens (HLA-DR)IBA 08/2009
1	Peptides (Polypeptides)IBA 08/2009

Therapy/Procedure

1	Percutaneous Coronary Intervention 12/2020
1	Therapeutics 12/2020